Matthew Baker

5G Evolution: A View on 5G Cellular Technology Beyond 3GPP Release 15

Amitabha Ghosh, Andreas Maeder, Matthew Baker et al. · IEEE Access · 2019 · 810 citations · Full text

Immunogenicity of protein therapeutics: The key causes, consequences and challenges

Matthew Baker, Helen Reynolds, Brooke Lumicisi et al. · Self/Nonself · 2010 · 349 citations · Full text

Immunodeficiencies, Immunology, Immunodominance +16

Highly Aggregated Antibody Therapeutics Can Enhance the in Vitro Innate and Late-stage T-cell Immune Responses

Marisa K. Joubert, Martha Hokom, Catherine M. Eakin et al. · Journal of Biological Chemistry · 2012 · 261 citations · Full text

Autoimmune Disease, Adaptive Immune System, T-regulatory Cell +11

Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics

Maryam Ahmadi, Christine Bryson, Edward A. Cloake et al. · Pharmaceutical Research · 2014 · 162 citations

Sub-visible Aggregates, Allergy, Monoclonal Antibody Therapeutics +10

In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab–MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios

Penny Bryant, Martin Pabst, George Badescu et al. · Molecular Pharmaceutics · 2015 · 122 citations

Immunology, Pharmacotherapy, Dar 4 +16